News & Reports

News and Reports

Select year

2024 2023 2022 2021 2020 Earlier
shown/page
10
5 10 15 20

2015.10.26

Lu Xianping was invited to attend 2015 international epigenomics symposium
Lu Xianping was invited to attend 2015 international epigenomics symposium

Full text

2015.09.28

"Revolution" of cancer diagnosis and treatment in CSCO conference from precision medicine to epigenetics
"Revolution" of cancer diagnosis and treatment in CSCO conference from precision medicine to epigenetics

Full text

2015.09.28

Dr. Lu Xianping received the life science achievement award from the US-China Biomedical and Pharmaceutical Association (SABPA)
Dr. Lu Xianping received the life science achievement award from the US-China Biomedical and Pharmaceutical Association (SABPA)

Full text

2015.09.23

High-end Dialogue at 2015 Shenzhen International BT leaders summit
High-end Dialogue at 2015 Shenzhen International BT leaders summit

Full text

2015.05.25

[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.
[ Leading scientific and technological innovation in China ] Lu Xianping: to be a life-saving medicine that people can afford.

Full text

2015.04.17

Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"
Shenzhen CHIPSCREEN BIOSCIENCES approved the establishment of " Shenzhen postdoctoral innovation practice base"

Full text

2015.02.17

Dr. Lu Xianping was invited to attend the " frontier seminar on tumor biology and new drug development" of the HongKong polytechnic University and give a report.
Dr. Lu Xianping was invited to attend the " frontier seminar on tumor biology and new drug development" of the HongKong polytechnic University and give a report.

Full text

2015.01.28

Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen
Chidamide press conference on original new drugs, national 863 and " major new drug discovery" special achievements held in Shenzhen

Full text

2015.01.09

The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!
The world's first subtype of selective histone deacetylase oral inhibitor original new drug Chidamide ( Epidaza? ) approved!

Full text

2014.12.21

CHIPSCREEN BIOSCIENCES, Shenzhen inspected by national major new drug discovery, science and technology major special supervision and evaluation team.
CHIPSCREEN BIOSCIENCES, Shenzhen inspected by national major new drug discovery, science and technology major special supervision and evaluation team.

Full text
Media contact

Media contact

  • Media contact

    (+86)0755-36993500

  • Media contact

    pr@chipscreen.com